Nelli Bejanyan

Cell Therapy Facility,
Department of Immunology

Moffitt Cancer Center and Research Institute

BIOGRAPHY

Nelli Bejanyan has not added Biography.

If you are Nelli Bejanyan and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study.

Transplantation and cellular therapy 01, 2021 | Pubmed ID: 33010430

Prognostic factors for clinical outcomes of patients with central nervous system leukemia.

Hematology/oncology and stem cell therapy Sep, 2021 | Pubmed ID: 33271117

First-line hypomethylating agents for patients with high risk chronic myelomonocytic leukaemia.

The Lancet. Haematology 02, 2021 | Pubmed ID: 33513378

ELN 2017 Genetic Risk Stratification Predicts Survival of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.

Transplantation and cellular therapy 03, 2021 | Pubmed ID: 33781526

INSTITUTIONS

Moffitt Cancer Center and Research Institute

JOVE ARTICLES

Expansion and Enrichment of Gamma-Delta (γδ) T Cells from Apheresed Human Product

Ana Marie Landin¹,

Cheryl Cox¹,

Bin Yu²,

Nelli Bejanyan^1,2,

Marco Davila^1,2,

Linda Kelley^1,2

¹Cell Therapy Facility, Moffitt Cancer Center and Research Institute,

²Department of Immunology, Moffitt Cancer Center and Research Institute

Cancer Research

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

Education

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Authors

Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit

Librarians

Overview
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

Nelli Bejanyan

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Cell Therapy Facility,Department of Immunology

Moffitt Cancer Center and Research Institute

Expansion and Enrichment of Gamma-Delta (γδ) T Cells from Apheresed Human Product

Cell Therapy Facility,
Department of Immunology